← Back to headlines
Apellis Pharma Stock Surges Following Biogen Deal
Apellis Pharma's stock has seen a significant surge following a deal with Biogen, leading investors to question if it's too late to capitalize on the APLS stock rally.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
Related Stories
Meta Introduces New Teen Safety Measures on Facebook and Instagram
20m ago
Netflix Unveils September Lineup Featuring Highly Rated Horror and Thriller Releases
2h ago
NASA Prepares to Launch Nancy Grace Roman Space Telescope
2h ago
Serbia Inaugurates First Humanoid Robot Manufacturing Plant in Šabac
5h ago